STRO-002

STRO-002 · Sutro Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for STRO-002, covering 2025-08-20 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors [Phase 1, Phase 2]

See pricing